Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 565

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 565
---
| Convertible Promissory Note — Others        |     |   | 1,395 |
| Accrued interest expense — Related Party    |     |   |    92 |
| Accrued interest expense — Others           |     |   |    68 |
| Total as of March 31, 2025                  |     | $ | 3,078 |

| (F) | Reflects the conversion of the Related Party Loan due to Scilex to equity. |

| (G) | Reflects the repayment of deferred underwriting and legal fees, which is being settled in a combination of cash 
 and shares.                                                                                                     |

| (In thousands)                                     |     |   |       |
|:---------------------------------------------------|:----|:--|------:|
| Cash repayment of deferred underwriting fees       |     | $ | 2,022 |
| Share settlement of the deferred underwriting fees |     |   |   866 |
| Total                                              |     | $ | 2,888 |

| (H) | Reflects the remaining carrying value of $9.1 million reflected as the reclassification of Denali 
 Class A Ordinary Shares from temporary equity to permanent equity.                                |

| (I) | Reflects conversion and recapitalization of Semnur Common Stock and Semnur Preferred Stock into New Semnur 
 Common Stock and New Semnur Class A Preferred Stock pursuant to the Merger Agreement.                      |

| (J) | Represents pro forma adjustments to additional paid-in capital balance 
 to reflect the following:                                              |

| (In thousands)                                                                                       |     |   |         |   |
|:-----------------------------------------------------------------------------------------------------|:----|:--|--------:|:--|
| Elimination of Historical Denali Retained Earnings                                                   |     | $ | (10,737 | ) |
| Represents reclassification of deferred transaction costs incurred by Semnur as of balance sheet     
 date                                                                                                 |     |   |  (6,817 | ) |
| Represents estimated transaction costs to be incurred by Denali and Semnur subsequent to the balance 
 sheet date                                                                                           |     |   |  (5,569 | ) |
| Reflects share repayment of Promissory Notes issued as of balance sheet date                         |     |   |   3,078 |   |
| Reflects share repayment of Promissory Notes issued subsequent to the balance sheet date             |     |   |      96 |   |
|